
Lenalidomide 25mg Capsule
Salt Composition: Lenalidomide
Expiry Date: 01/2028
Inclusive of all taxes
30 capsule
About The Product
Blood Cancer
Lenalidomide 25mg Capsule is an immunomodulatory drug derived from thalidomide. It is a prescription-based anticancer medicine used to treat Multiple Myeloma, Myelodysplastic Syndromes, and Mantle Cell Lymphoma. This medicine contains immunomodulatory and antiangiogenic properties, and it works by affecting the functioning of the immune system & slowing down the growth of cancer cells.
Side Effects
- Like any other anticancer medicine, Lenalidomide 25mg Capsule also has some adverse effects on the body, and most of them are manageable without special medical attention.
- Some common side effects include: Confusion Swelling Respiratory disorder Bleeding gums Blood clots Anxiety Muscle pain Dry skin Constipation Rash Cough Nausea Sore throat Vomiting Seek medical attention immediately in case of any severe side effects.
How To Use
- The dosage of the capsule is usually decided by the doctor as per the patient's health condition, stage & type of cancer.
- Lenalidomide 25mg Capsule should be swallowed as a whole with water.
- It should not be crushed, chewed, or cut.
- In case you experience symptoms of overdose, immediately call your doctor or any other medical emergency helpline.
How It Works
Lenalidomide 25mg Capsule is an anti-cancer medication. It works by enhancing the immune system's functioning, which indirectly attacks the cancer cells.
It prevents the growth of new blood vessels within the tumor. It also restricts the production of chemical messengers (cytokines and growth factors), which are responsible for the growth of cancer cells.
Safety Advice
Missed Doses
- Initially, it is advisable to not miss a dose of lenalidomide 10mg capsule.
- However, if such a case happens, make sure to consult your healthcare provider to schedule an appointment for the same or guide you further.
FAQs
Lenalidomide 25mg Capsules is an anti-cancer medication, prescribed for the treatment of Multiple Myeloma, Myelodysplastic Syndromes, and Mantle Cell Lymphoma.
Reference
1.https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021880s034lbl.pdf
2. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1b2716cf-24b4-4157-a218-58ede63917bd
3.https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021880s006s016s017lbl.pdf
4. Armoiry, X., Aulagner, G., & Facon, T. (2008). Lenalidomide in the treatment of multiple myeloma: a review. Journal of clinical pharmacy and therapeutics, 33(3), 219-226.
5. Rao, K. V. (2007). Lenalidomide in the treatment of multiple myeloma. American Journal of Health-System Pharmacy, 64(17), 1799-1807.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
.jpeg%3FupdatedAt%3D1763121181831&w=128&q=75)
